SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : World Heart Corp - WHRT and TSE/WHT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: the Chief who wrote (191)1/21/1999 10:33:00 PM
From: L M  Read Replies (1) of 500
 
I think the ramp up this week may represent a mild precursor to future events with this stock. One might equate this week's activity to those early warning "get ready" tremors associated with a mighty and explosive volcanic eruption. It was only recently that I came across one of your (OT) posts regarding World Heart and I decided to request an info package from the company. Very impressive indeed. It is the first such package that I have received which included a CD video presentation of the company and it's product. This company has certainly picked a lucrative arena, in which to become a leading edge player, and one that is being enhanced tremendously by a very captive audience - aging yuppies (I am one so I can say this) with guaranteed heart problems (Hope this part won't apply to me), including the ever increasing incidence of congestive heart failure. I concur with your assessment that this company and it's product (initial human implant and trial is plan scheduled in Canada towards the end of this year) may well parallel that of a Microsoft in terms of stock valuation and appreciation over the next five years. I seem to recall that you may have recently and boldly predicted a share price of $17,000.00 (after splits, I assume and presume) by the year 2005 and predicated of course on human trials success, various European country approvals, and culminating in the all important approval of USA (FDA) with it's tremendous product sales potentials. This situation and stock valuation potential seems to be further solidified and enhanced by the stock distribution - insiders and proclaimed long-term holders appear to be in the overwhelming majority. Even if you are only half right on a trials success based scenario, this could conceivably be a once in a lifetime opportunity/proposition for the increasingly rare long view shareholder. In other words, if all goes well, that MD gap we saw earlier this week between $28.00 and $50.00 on the offer will seem frightfully small.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News